Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107522743A enables high-purity TAF synthesis. Enhances supply chain reliability and reduces manufacturing costs for antiviral intermediates.
Novel copper-based photocatalysis method for 6-cyclohexylphenanthridine. Reduces solvent use, enables room temperature reaction, ensuring reliable pharmaceutical intermediate supply.
Patent CN109678718B reveals a green one-step method for phenylpropionate derivatives. Achieve high purity and cost reduction in pharma intermediate manufacturing.
Patent CN101628889A reveals a high-yield toluene-based route for Donepezil key intermediates, offering significant cost and purity advantages for API manufacturers.
Novel Rh-catalyzed C-H activation for 3-aminoindanones. High yield, atom economy, scalable pharma intermediate manufacturing.
Patent CN106046095A reveals mild synthesis route. Reduces LDA use significantly. Reliable supply chain partner for commercial scale-up and high purity API intermediates.
Patent CN103145574A reveals a cost-effective Diclofenac route using N-chloroamide cyclization. Ideal for reliable pharmaceutical intermediates supplier seeking scalable API manufacturing.
Patent CN109608411A details a robust 5-step synthesis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global buyers.
Novel patent CN117342985B offers safer lenvatinib intermediate synthesis. Avoids toxic chloroformates, ensuring high purity and scalable supply chain reliability for global procurement.
Patent CN103755706A details a novel glycerol-based route for folic acid, eliminating toxic trichloroacetone and reducing waste for cost-effective API manufacturing.
Patent CN107235910B reveals a high-purity synthesis route for Nilotinib intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Novel patent CN108623598A details improved Imipenem synthesis reducing impurities and enhancing crystallinity for reliable pharmaceutical intermediate supply chains.
Patent CN104744350A details a novel Suzuki coupling route for VEGFR-2 inhibitors. This method ensures cost reduction in API manufacturing and supply chain reliability.
Novel 6-step synthesis for quinolone intermediate CN105801482B. High purity over 99 percent, reduced pollution, scalable process for reliable pharmaceutical intermediates supplier.
Patent CN100548979C details a metal-free, high-yield route to optically active 3-aminoindoles using chiral phosphoric acids, offering significant supply chain advantages.
Patent CN108997339A reveals efficient Rh-catalyzed synthesis for isoindole isoquinoline carboxylates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN113354623A reveals a novel thiourea dioxide reduction route for ilaprazole intermediates, offering superior purity and cost efficiency for API manufacturing.
Novel diisopropylamine environment method for phenanthrene compounds. High yield, scalable process for pharmaceutical intermediates. Reliable supply chain partner.
Patent CN112409235A details a Rh-catalyzed asymmetric hydrogenation route for chiral 4-halogenated tryptophan derivatives with 99.9% ee, offering a scalable solution for API intermediates.
Patent CN101921229B details a novel asymmetric catalytic hydrogenation route for L-Stepholidine. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.